Abstract
Inhibitors of apoptosis (IAPs) inhibit caspases, thereby preventing proteolysis of apoptotic substrates. IAPs occlude the active sites of caspases to which they are bound1,2,3 and can function as ubiquitin ligases. IAPs are also reported to ubiquitinate themselves and caspases4,5. Several proteins induce apoptosis, at least in part, by binding and inhibiting IAPs. Among these are the Drosophila melanogaster proteins Reaper (Rpr), Grim, and HID, and the mammalian proteins Smac/Diablo and Omi/HtrA2, all of which share a conserved amino-terminal IAP-binding motif6,7,8,9,10,11,12,13,14. We report here that Rpr not only inhibits IAP function, but also greatly decreases IAP abundance. This decrease in IAP levels results from a combination of increased IAP degradation and a previously unrecognized ability of Rpr to repress total protein translation. Rpr-stimulated IAP degradation required both IAP ubiquitin ligase activity and an unblocked Rpr N terminus. In contrast, Rpr lacking a free N terminus still inhibited protein translation. As the abundance of short-lived proteins are severely affected after translational inhibition, the coordinated dampening of protein synthesis and the ubiquitin-mediated destruction of IAPs can effectively reduce IAP levels to lower the threshold for apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Riedl, S. J. et al. Cell 104, 791– 800 (2001).
Huang, Y. et al. Cell 104, 781– 790 (2001).
Chai, J. et al. Cell 104, 769– 780 (2001).
Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M. & Ashwell, J. D. Science 288, 874– 877 (2000).
Huang, H. et al. J. Biol. Chem. 275, 26661– 26664 (2000).
White, K., et al. Science 264, 677– 683 (1994).
Goyal, L., McCall, K., Agapite, J., Hartwieg, E. & Steller, H. EMBO J. 19, 589– 597 (2000).
Wu, G. et al. Nature 408, 1008– 1012 (2000).
Wu, J. W., Cocina, A. E., Chai, J., Hay, B. A. & Shi, Y. Mol. Cell 8, 95– 104 (2001).
Verhagen, A. M. et al. Cell 102, 43– 53 (2000).
Suzuki, Y. et al. Mol. Cell 8, 613– 621 (2001).
Martins, L. M. et al. J. Biol. Chem. 277, 439– 444 (2002).
Chen, P., Nordstrom, W., Gish, B. & Abrams, J. M. Genes Dev. 10, 1773– 1782 (1996).
Grether, M. E., Abrams, J. M., Agapite, J., White, K. & Steller, H. Genes Dev. 9, 1694– 1708 (1995).
Newmeyer, D. D., Farschon, D. M. and Reed J. C. Cell 79, 353– 364 (1994).
Glotzer, M., Murray, A. & Kirschner, M. Nature 349, 132– 138 (1991).
Avdonin, V. et al. Proc. Natl Acad. Sci. USA 95, 11703– 11708 (1998).
Richter, B. W. & Duckett, C. S. Science STKE [online] (cited 8 August 2000) http://stke.sciencemag.org/cgi/content/full/OC_sigtrans;2000/44/pe1 (2000).
Clem, R. J. et al. J. Biol. Chem. 276, 7602– 7608 (2001).
Deveraux, Q. L. et al. EMBO J. 18, 5242– 5251 (1999).
Evans, E. K. et al. EMBO J. 16, 7372– 7381 (1997).
Swenson, K. I., Jordan, J. R., Beyer, E. C. & Paul, D. L. Cell 57, 145– 155 (1989).
Ryoo, H.D. et al. Nature Cell Biol. DOI:10.1038/ncb795.
Hays, R. et al. Nature Cell Biol. DOI:10.1038/ncb794.
Wing, J.P. et al. Nature Cell Biol. DOI:10.1038/ncb800.
Yoo, S.J. et al. Nature Cell Biol. DOI:10.1038/ncb793.
Acknowledgements
We thank B. Kaplan for his generous provision of the Rpr peptide. We are grateful to B. Hay for provision of DIAP clones and for helpful discussion. We thank C. Duckett for generously providing XIAP-expression clones. We also thank B. Mayer for the Xenopus cDNA library and M. Hardwick for providing the c-IAP clone. This work was supported by a National Institutes of Health grant to S.K. (RO1 GM61919). S.K. is a Scholar of the Leukemia and Lymphoma Society. D.C.R. is a Gates Millenium Fellow. C.H. and M.O. are predoctoral fellows of the US Army Medical Research and Material Command Breast Cancer Research Program, as well as the NIH Medical Scientist Training Program.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Holley, C., Olson, M., Colón-Ramos, D. et al. Reaper eliminates IAP proteins through stimulated IAP degradation and generalized translational inhibition. Nat Cell Biol 4, 439–444 (2002). https://doi.org/10.1038/ncb798
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb798
This article is cited by
-
Genetic characterization of two gain-of-function alleles of the effector caspase DrICE in Drosophila
Cell Death & Differentiation (2016)
-
Cullin-4 regulates Wingless and JNK signaling-mediated cell death in the Drosophila eye
Cell Death & Disease (2016)
-
The initiator caspase Dronc is subject of enhanced autophagy upon proteasome impairment in Drosophila
Cell Death & Differentiation (2016)
-
Suppression of induced but not developmental apoptosis in Drosophila by Ayurvedic Amalaki Rasayana and Rasa-Sindoor
Journal of Biosciences (2015)
-
The deubiquitinating enzyme DUBAI stabilizes DIAP1 to suppress Drosophila apoptosis
Cell Death & Differentiation (2014)